We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.32%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
-$37.8M
(-0.35%)
Cap. Flow
-$908M
Cap. Flow
% of AUM
-8.31%
Top 10 Holdings %
Top 10 Hldgs %
26.48%
Holding
575
New
13
Increased
189
Reduced
344
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Water Works
AWK
|
+$17.5M |
| 2 |
Charles River Laboratories
CRL
|
+$5.78M |
| 3 |
Caesars Entertainment
CZR
|
+$5.73M |
| 4 |
Lyft
LYFT
|
+$5.26M |
| 5 |
Bio-Techne
TECH
|
+$5.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$290M |
| 2 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$60.1M |
| 3 |
Apple
AAPL
|
+$41.7M |
| 4 |
Tesla
TSLA
|
+$33.3M |
| 5 |
Microsoft
MSFT
|
+$27.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.49% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 13.89% |
| 4 | Consumer Discretionary | 11.7% |
| 5 | Communication Services | 11.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Prudential Financial
PRU
$42.8B
| $14.6M | 0.13% |
142,038
+18,900
| +15% | +$1.93M |
|
152
Vertex Pharmaceuticals
VRTX
$119B
| $14.5M | 0.13% |
71,735
-5,600
| -7% | -$1.17M |
|
153
Idexx Laboratories
IDXX
$44.5B
| $14.4M | 0.13% |
22,874
-400
| -2% | -$221K |
|
154
Veeva Systems
VEEV
$33.5B
| $14.3M | 0.13% |
45,993
-700
| -1% | -$195K |
|
|
DOCU
155
DocuSign
DOCU
$10.6B
| $14.3M | 0.13% |
51,100
-10,000
| -16% | -$2.24M |
|
156
Dollar General
DG
$28.3B
| $14.3M | 0.13% |
65,903
-6,800
| -9% | -$1.43M |
|
157
PPG Industries
PPG
$25.3B
| $14.3M | 0.13% |
83,963
+1,500
| +2% | +$257K |
|
158
TE Connectivity
TEL
$59.8B
| $14.1M | 0.13% |
104,615
-500
| -0.5% | -$67K |
|
159
Public Storage
PSA
$60.8B
| $14M | 0.13% |
46,604
-3,600
| -7% | -$1.01M |
|
160
KLA
KLAC
$238B
| $13.9M | 0.13% |
430,000
-31,000
| -7% | -$993K |
|
161
Agilent Technologies
A
$39.6B
| $13.6M | 0.12% |
91,783
-7,600
| -8% | -$1.04M |
|
162
MSCI
MSCI
$41.9B
| $13.5M | 0.12% |
25,390
-2,000
| -7% | -$953K |
|
163
Aptiv
APTV
$12B
| $13.5M | 0.12% |
85,859
-4,300
| -5% | -$630K |
|
164
Roku
ROKU
$21.7B
| $13.4M | 0.12% |
29,100
-7,400
| -20% | -$2.62M |
|
165
Trane Technologies
TT
$102B
| $13.3M | 0.12% |
72,393
-3,000
| -4% | -$534K |
|
166
Constellation Brands
STZ
$22.5B
| $13.2M | 0.12% |
56,429
+200
| +0.4% | +$47K |
|
|
BNY
167
Bank of New York Mellon
BNY
$106B
| $13.2M | 0.12% |
257,180
+16,400
| +7% | +$821K |
|
168
International Flavors & Fragrances
IFF
$20.5B
| $13M | 0.12% |
87,311
+12,000
| +16% | +$1.72M |
|
169
T. Rowe Price
TROW
$24.3B
| $13M | 0.12% |
65,814
+1,700
| +3% | +$318K |
|
170
Allstate
ALL
$67.5B
| $13M | 0.12% |
99,769
+12,300
| +14% | +$1.59M |
|
171
Match Group
MTCH
$9.48B
| $12.9M | 0.12% |
80,144
-4,400
| -5% | -$645K |
|
172
Centene
CNC
$31.5B
| $12.9M | 0.12% |
177,050
-3,900
| -2% | -$267K |
|
173
Kimberly-Clark
KMB
$35.8B
| $12.8M | 0.12% |
95,360
-2,700
| -3% | -$360K |
|
174
Align Technology
ALGN
$12.3B
| $12.6M | 0.12% |
20,688
-900
| -4% | -$533K |
|
175
Illinois Tool Works
ITW
$82.9B
| $12.5M | 0.11% |
55,957
-18,000
| -24% | -$4.12M |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q2 2021 Portfolio in Review
As of Q2 2021, Fjarde Ap-fonden held 575 positions worth $10.9B, down 0.35% from $11B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Fjarde Ap-fonden withdrew a net $908M in Q2 2021, closing 9 positions and reducing 344 holdings. Its most notable exit was Consolidated Edison, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fjarde Ap-fonden opened a new position in Charles River Laboratories worth $6.4M.
- Fjarde Ap-fonden's largest Q2 2021 buy was Charles River Laboratories: 17,300 shares worth $6.4M.
- Fjarde Ap-fonden added most to American Water Works in Q2 2021, an estimated $17.5M increase.
- Fjarde Ap-fonden's biggest Q2 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $290M.
- Fjarde Ap-fonden fully exited Consolidated Edison in Q2 2021, selling an estimated $21.6M.
- Fjarde Ap-fonden's ten largest holdings make up 26% of its $10.9B portfolio in Q2 2021.
- Fjarde Ap-fonden opened 13 new positions and closed 9 in Q2 2021.
- Fjarde Ap-fonden's portfolio value fell 0.35% quarter-over-quarter to $10.9B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2021, filed 12 Aug 2021.